Segment and Geographical Information (Tables)

9 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

The tables below present segment revenue, operating income (loss) and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2019			2018			2019			2018
Revenue:
Medical Device	$	18,945		$	16,701		$	53,504		$	43,527
In Vitro Diagnostics		5,399			5,526			15,757			14,771
Total revenue	$	24,344		$	22,227		$	69,261		$	58,298
Operating income (loss):
Medical Device	$	753		$	(6,193	)	$	1,087		$	(6,351	)
In Vitro Diagnostics		2,475			2,176			7,845			6,269
Total segment operating income		3,228			(4,017	)		8,932			(82	)
Corporate		(2,211	)		(2,233	)		(6,338	)		(6,277	)
Total operating income (loss)	$	1,017		$	(6,250	)	$	2,594		$	(6,359	)
Depreciation and amortization:
Medical Device	$	1,481		$	1,333		$	4,315		$	3,929
In Vitro Diagnostics		120			101			353			291
Corporate		286			171			794			491
Total depreciation and amortization	$	1,887		$	1,605		$	5,462		$	4,711